Dongin Biotech Co. Ltd agreed to acquire GTG Wellness Co., Ltd. (KOSDAQ:A219750) in reverse merger transaction on February 2, 2024. When the merger between Dongin Biotech Co. Ltd and GTG Wellness Co., Ltd. (KOSDAQ:A219750) is completed, GTG Wellness Co., Ltd becomes the surviving corporation, and Dongin Biotech Co. Ltd becomes a extinguished corporation. Transaction is expected to complete on March 29, 2024. The revised date of merger registration is April 26, 2024 and the new shares shall be listed on May 27, 2024.

Dongin Biotech Co. Ltd completed the acquisition of GTG Wellness Co., Ltd. (KOSDAQ:A219750) in reverse merger transaction on March 29, 2024.